Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

304
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
304
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innate Immune Cell and Epithelial Subsets Coordinate Airway Responses to Allergen.

American journal of respiratory cell and molecular biology·2026
Same author

The authors reply.

Critical care medicine·2026
Same author

Quantitative Proteomic Profiling of Bronchoalveolar Lavage-Derived Extracellular Vesicles in a Murine Asthma Model.

Chemical research in toxicology·2026
Same author

Gene-Level Analyses of Novel Olfactory-Related Signal from Severe SARS-CoV-2 GWAS Reveal Association with Disease Mortality.

COVID·2026
Same author

The authors reply.

Critical care medicine·2025
Same author

To B or Not to B: Germinal Center Responses in Progressive Fibrotic Interstitial Lung Disease.

American journal of respiratory and critical care medicine·2025

Related Experiment Video

Updated: May 22, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K

Innate Immunity and Asthma Exacerbations: Insights From Human Models.

Jehan Alladina1, Benjamin D Medoff1, Josalyn L Cho2

  • 1Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Immunological Reviews
|March 15, 2025
PubMed
Summary

Understanding innate immunity in asthma exacerbations is crucial for developing new treatments. This review covers current knowledge and identifies novel therapeutic targets for better asthma management.

Keywords:
asthma exacerbationsinnate immunitysegmental allergen challengetype 2 inflammation

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.3K

Related Experiment Videos

Last Updated: May 22, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.3K

Area of Science:

  • Immunology
  • Pulmonology
  • Respiratory Medicine

Background:

  • Asthma is a chronic respiratory disease marked by airway inflammation and hyperresponsiveness, often leading to irreversible airflow obstruction.
  • Type 2 airway inflammation drives most asthma cases, and while targeted therapies exist, they are not universally effective, necessitating further research into alternative pathways.
  • Gaps remain in understanding the innate immune response during asthma exacerbations, which is the initial inflammatory event.

Purpose of the Study:

  • To review the current understanding of innate immunity's role in asthma exacerbations.
  • To discuss methods used to study innate immunity in asthma.
  • To identify novel therapeutic targets and future research directions for asthma.

Main Methods:

  • Literature review of studies on innate immunity and asthma exacerbations.
  • Analysis of current therapeutic approaches and their limitations.
  • Identification of knowledge gaps in innate immune responses.

Main Results:

  • Innate immunity activation is a key early event in asthma exacerbations.
  • Current type 2-targeted therapies show incomplete efficacy, highlighting the need for broader strategies.
  • Significant gaps exist in understanding the innate immune response to asthma triggers.

Conclusions:

  • Further investigation into the innate immune system is essential for developing more effective asthma treatments.
  • Targeting additional pathways beyond type 2 inflammation may be necessary for asthma remission.
  • Identifying novel therapeutic targets in innate immunity holds promise for future asthma management.